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Abstract:
Mycobacterium Haemophilum is a rare infection that can present in 
humans as subcutaneous nodules and cutaneous lesions.  With a 
growing number of immunocompromised patients, M. Haemophilum 
infections are becoming more common.  Rheumatoid nodules in 
comparison are very common and can occur in approximately 25% of 
patients with Rheumatoid Arthritis (RA).  Here we discuss a case in a 
patient with Rheumatoid Arthritis who developed subcutaneous nodules 
that mimicked rheumatoid nodules, but were later determined to be 
infectious nodules from Mycobacterium Haemophilum. 
Background:
Mycobacterium Haemophilum is a rare non-tuberculous Acid Fast 
Bacillus that is becoming more common with increasing number of 
immunocompromised patients in the United States. M. Haemophilum has 
been isolated from the environment, specifically water reservoirs.  It has 
also been observed in some animals and in humans.  Etiology in most 
patients remains unclear, but there have been cases reported after 
surgeries, procedures, acupuncture, and tattoos.3 M. Haemophilum is 
known for its difficult growth requirements including need for iron hence in 
its name Haemophilum “blood loving.”2  In addition it requires lower 
incubation temperatures to grow (30˚C).3 Given these difficult growth 
requirements, Clinicians need to be mindful of this organism or it can 
evade diagnosis.  
M. Haemophilum most commonly presents as subcutaneous nodules and 
cutaneous lesions occurring on the extremities especially over joints.  But 
can also present as cervicofacial lymphadenitis, septic arthritis, 
osteomyelitis, and pneumonitis.  If not promptly treated M. Haemophilum 
nodular cutaneous lesions can progress to deep cutaneous lesions and 
further progress to disseminated disease.1
Rheumatoid arthritis is the most commonly diagnosed inflammatory 
arthritis in the United States.  Rheumatoid nodules are a common 
dermatologic manifestation of RA.  RA nodules are commonly located 
subcutaneously along the extensor surface of joints especially at the 
olecranon process.  Rheumatoid nodules are more common in patients 
with seropositive RA and are typically non-tender.  Rheumatoid arthritis 
patients on immunosuppressive treatments are at increased risk for M. 
Haemophilum.  Given this increased risk and similarity of location of 
nodules M. Haemophilum nodules can mimic RA nodules.  
Pictured below example of Rheumatoid Nodule of the thumb4:
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Case Presentation: 
Patient is a 66 year old female diagnosed originally with Seronegative 
Rheumatoid Arthritis after presenting to rheumatology with complaints 
of pain in bilateral wrists, myalgias, morning stiffness and fatigue.  
Physical examination was positive for swelling bilateral wrists and 1st 
MCP joints bilaterally.  No obvious nodules at that time.  Patient was 
originally treated with methotrexate, but had continued symptoms of 
right hand pain.  MRI of the right hand at that time showing joint 
erosions of the 1st MCP, 1st DIP with acute inflammatory component 
consistent with rheumatoid arthritis.  Patient was switched to Humira 
(Adalimumab) with improvement in symptoms.  
After 3 years of improvement in symptoms and decreased pain, patient 
presented with complaint of pain in the right hand.  She had an MRI of 
the right hand showing acute synovitis and tenosynovitis throughout the 
hand with multiple joint erosions consistent with inflammatory 
arthropathy.  In addition multiple subcutaneous soft tissue nodules were 
present.  Patient at that time was switched from Humira to Enbrel 
(Etanercept). 
Several months later the patient presented with complaint of nodule on 
the left elbow.  Physical exam positive for large palpable subcutaneous 
nodule on the extensor surface of the left elbow, limiting range of 
motion.  She was referred to surgery.  She had biopsy done by surgery 
showing tissue with chronic inflammatory changes.  Fluid drained from 
the elbow appeared yellow and was sent for analysis.  Aerobic and 
anaerobic cultures were negative.  AFB smear was negative.  The 
patient was switched to Orencia (Abatacept). 
Patient 6 months later self referred to surgery for carpal tunnel 
syndrome of the right hand.  She had flexor tenosynovectomy, palmar 
tenosynovectomy and steroid injection of the right thumb flexor sheath.  
Surgical specimen sent smear and cultures.  Cultures were negative, 
but AFB smear came back positive.  Patient was referred to Infectious 
Disease who started patient on Moxifloxacin, Clarithromycin and 
Ethambutol.  
Despite treatment with antibiotics patient had a new large nodule that 
formed on the right thumb.  She had debridement of the right thumb 
and flexor sheath.  Specimen was sent for smear and culture which 
were negative.  Same specimen was sent out to University of 
Washington Molecular Diagnosis Microbiology Lab a lab specialized in 
the detection of direct detection of Acid-Fast Bacilli DNA from tissues.  
PCR using rpOB primary set showed Mycobacterium Haemophilum 
from specimen of the right thumb tenosynovium.  Patient had regrowth 
of nodule in the right thumb and extensor tendon of the wrist and 
required repeat debridement.  Pathology revealed necrotizing 
granulomatous inflammation.  Patient completed over 1 year of 
treatment with Moxifloxacin, Clarithromycin, and Ethambutol with 
resolution of nodules. 
Discussion: 
Mycobacterium Haemophilum can present as a cutaneous 
infection in Immunocompromised patient that can mimic 
Rheumatoid nodules.  Nodules in early stages M. 
Haemophilum infection and Rheumatoid nodules can both 
occur along the extensor surfaces of joints making them 
difficult to distinguish.   Rheumatoid arthritis patients on 
immunosuppressive treatments are at increased risk for M. 
Haemophilum.  Given this increased risk and similarity of 
location of nodules M. Haemophilum nodules can mimic RA 
nodules.  The Clinician should have M. Haemophilum on their 
differential for a new nodule in a patient with Rheumatoid 
Arthritis.  Cultures and Acid Fast Smear can be negative and 
should not eliminate the M. Haemophilum from the differential 
diagnosis.  M. Haemophilum cultures can take up to 6 weeks 
to grow even at the proper temperature and medium.  Use of 
PCR to assess tissue samples for M. Haemophilum can aid in 
the diagnosis.  If clinically suspected immunosuppression 
medication should be stopped and patient should be started 
on triple antibiotic therapy.  There are no guidelines to 
treatment in the literature clarithromycin, ciprofloxacin, and 
rifamycin have been used for at least 12 to 24 months.
MRI Right thumb showing nodule 
